Cubist Systematic Strategies »

Summit Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2025-03-31 $363k 19k 19.29
2024-12-31 $336k 19k 17.85
2024-09-30 $412k 19k 21.90

More positions owned by Cubist Systematic Strategies

Spdr Gold Tr Gold Shs (GLD)
Oracle Corporation Call Option (ORCL)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Palantir Technologies Cl A Call Option (PLTR)
UnitedHealth Call Option (UNH)
Robinhood Mkts Com Cl A Call Option (HOOD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Select Sector Spdr Tr Energy Call Option (XLE)
Nebius Group Shs Class A Call Option (NBIS)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Wal-Mart Stores (WMT)

View all positions for Cubist Systematic Strategies

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics